Predictive Safety Testing Consortium Submits First Biomarkers to FDA for Qualification | GenomeWeb
ATLANTA (GenomeWeb News) – The Predictive Safety Testing Consortium, a collaboration of industry, academia, and government research groups with the goal of developing safety biomarkers for preclinical studies, has submitted its first biomarker “qualification package” for US Food and Drug Administration review, according to several PSTC participants who spoke at the Drug Industry Association annual meeting, held here this week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.